TP53 and neoplasm: In vivo experiments suggest that early-infiltrating neutrophils may initially inhibit tumor progression, but this function is lost as tumors progress, leading to a pro-tumor functional phenotype, particularly in tumor protein P53 (TP53)-induced GBM [320].